S-Frame CT Immobilization Masks For Patients Undergoing Radiation Therapy For Head and Neck Cancer - Full Text View

S-Frame CT Immobilization Masks For Patients Undergoing Radiation Therapy For Head and Neck Cancer

This study is currently recruiting participants.
Verified by University Health Network, Toronto, October 2005

Sponsors and Collaborators:	University Health Network, Toronto Princess Margaret Hospital, Canada
Information provided by:	University Health Network, Toronto
ClinicalTrials.gov Identifier:	NCT00252473

Purpose

Immobilization devices such as thermoplastic masks are used routinely in the radiation treatment of head and neck cancer patients. It is important to assess how well they function at preventing patient motion while the radiation treatment is being delivered. (i.e. isocentre set-up margins, patient motion with the mask). If these new thermoplastic masks such as MedTec S-frame allow less movement, then smaller margins are needed during radiation therapy which, in turn, would decrease side effects from the treatment.

Condition	Intervention	Phase
Head and Neck Neoplasms	Device: MedTec S-frame Immobilization Masks	Phase II

MedlinePlus related topics:

Cancer Head and Neck Cancer

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Treatment, Non-Randomized, Open Label, Active Control, Single Group Assignment, Safety/Efficacy Study

Official Title:	Evaluation of Setup Accuracy in Med Tec S-Frame Immobilization Masks For Patients Undergoing Radiation Therapy For Head and Neck Cancer

Further study details as provided by University Health Network, Toronto:

Primary Outcome Measures:

Measurement of the accuracy of MedTec S-frame head and neck immobilization system (isocentre set-up accuracy, patient movement margins and movement of the normal tissue critical structures and planning target volumes)

Estimated Enrollment:	30
Study Start Date:	January 2005

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Histological confirmation of mucosal malignancy in the head and neck (H&N) region
Undergoing radiotherapy (RT) with curative intent using a lateral parallel pair treatment with an anterior or anterior/posterior low neck filed technique using a MedTec S-frame mask

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00252473

Contacts


Contact: Andrew Bayley, MD	416-946-2919	andrew.bayley@rmp.uhn.on.ca

Locations


Canada, Ontario
	University Health Network	Recruiting
	Toronto, Ontario, Canada, M5G 2M9
	Contact: Andrew Bayley, MD 416-946-2919 andrew.bayley@rmp.uhn.on.ca

Sponsors and Collaborators

University Health Network, Toronto

Princess Margaret Hospital, Canada

Investigators


Principal Investigator:	Andrew Bayley, MD	Princess Margaret Hospital, Canada

More Information

Study ID Numbers:	UHN REB 02-0832-C
First Received:	November 9, 2005
Last Updated:	February 10, 2006
ClinicalTrials.gov Identifier:	NCT00252473
Health Authority:	Canada: Ethics Review Committee

Study placed in the following topic categories:

Head and Neck Neoplasms

Additional relevant MeSH terms:

Neoplasms

Neoplasms by Site

ClinicalTrials.gov processed this record on September 05, 2008